Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis

作者：Satoshi Washino, Suguru Shirotake, Hideki Takeshita, Masaharu Inoue, Yuji Miura, Yoji Hyodo, Makoto Kagawa, Keita Izumi, Masafumi Oyama, Satoru Kawakami, Kazutaka Saito, Yoh Matsuoka, Satsuki Taniuchi, Ayumi Shintani, Tomoaki Miyagawa · 发表于：International Journal of Clinical Oncology · 年份：2023 · DOI：10.1007/s10147-023-02406-x · 被引用次数：24 · 研究领域：Cancer Immunotherapy and Biomarkers、Renal cell carcinoma treatment、Ferroptosis and cancer prognosis